Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-216.89M
↓ 158% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-83.92M
Historical baseline
PeriodValueYoY Change
TTM$-216.89M-59.5%
2024$-135.97M-78.1%
2023$-76.32M-20.5%
2022$-63.32M+5.1%
2021$-66.74M-22.7%
2020$-54.40M+31.8%
2019$-79.82M-56.1%
2018$-51.12M+13.0%
2017$-58.73M-63.5%
2016$-35.92M-